WE EMPOWER COMPANIES AT ANY STAGE TO BUILD INDUSTRY-LEADING ENTERPRISES IN CRITICAL SECTORS.

Retained by multiple Insurance companies to advise on various transactions resulting in a $6.7 Billion investment from Warren Buffett.

Retained by Pfizer (NYSE: PFE) to support on various Acquisition, Divestiture and Capital Raises over 10+ years.

Generated and advised on $20 Billion+ in M&A transactions over 3+ years.

Retained by Pfizer (NYSE: PFE) to advise on the largest pharma transaction in history, the $160 Billion merger of Pfizer (NYSE: PFE) with global pharmaceutical company Allergan plc (NYSE:AGN).

Raised $100 Million for ACI Worldwide (NASDAQ: ACIW) on the cash sale of its corporate online banking solutions to middle market private equity firm, One Equity Partners.

Retained by TransUnion (NYSE: TRU) on The Acquisition Of Verisk Financial (NASDAQ: VRSK) for $1.2 Billion. Strategy+ negotiated savings of $700M against JP Morgan & McKinsey in the DD process.

Retained by Pfizer (NYSE: PFE) on the $12 Billion merger of UpJohn and Mylan into Viatris (NASDAQ: VTRS).

Retained by Pfizer (NYSE: PFE) on the $810 Million Acquisition of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare disease.

Retained by Aon (NYSE: AON) on the sale of R.E & Investment advisory firm The Townsend Group to an investment group led by The Riverside Company.

Retained by Johnson & Johnson (NYSE: JNJ) to support on various Acquisition, Divestiture and Capital Raises.

Retained by Pfizer (NYSE: PFE) to advise on the $18 Billion joint venture with GlaxoSmithKline plc (NYSE:GSK), creating a premier global consumer healthcare company.

Retained by PE Firm Clayton Dubilier & Rice, LLC for the $15.5 Billion acquisition of Truist Insurance Holdings.

Retained by Securian Financial for the sale of various business units including the Retail Wealth Business to Cetera and the Retirement Plan Recordkeeping Business to The Standard.

Retained by Aon (NYSE: AON) for the sale of 20+ business units to various entities.

Generated and advised on $30 Billion+ in M&A transactions over 7+ years.

Retained by PE Firm Clayton Dubilier & Rice, LLC to support on various Acquisitions and Deal Origination.

Retained by Pfizer (NYSE: PFE) on the $17 Billion Acquisition of Hospira, Inc (NYSE: HSP), the world’s leading provider of injectable drugs and infusion technologies.

Retained by Pfizer (NYSE: PFE) on the $11.4 Billion Acquisition of Array Biopharma (NASDAQ: ARRY), a commercial stage biopharmaceutical company.

Retained by Pfizer (NYSE: PFE) on the $14 Billion Acquisition of Medivation, Inc. (NASDAQ: MDVN).

Retained by Pfizer (NYSE: PFE) on the $5.2 Billion Acquisition of Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC).

Retained by Aon (NYSE: AON) for the $1.4 Billion sale of its Retiree Health Exchange business to Alight (NYSE: ALIT).

Retained by Pfizer (NYSE: PFE) on the $1 Billion sale of Hospira Infusion Systems (HIS) to ICU Medical.

Retained by Aon (NYSE: AON) for the sale of Healthy Paws to Chubb Limited (NYSE: CB) driving investments from Warren Buffett.

Retained by NSM Insurance Group for deal origination and due diligence of various Acquisition targets.

Retained by Aon (NYSE: AON) for the sale of Stroz Friedberg to TCDI, an innovative eDiscovery services business backed by PF firm Trivest Partners.

Retained by NRT Technology for deal origination and due diligence of various Acquisition targets.

Retained by Sightline Payments for deal origination and due diligence of various Acquisition targets.

Retained by VyStar Credit Union to advise on the merger with 121 Financial Credit Union.